Long COVID Recovery: Timeline, Strategies, and When to Seek Help

Long COVID recovery usually takes months rather than weeks: many people improve gradually over 12 to 24 months, but progress is uneven and a minority still have symptoms years later. In the Long-COVID in Scotland Study (Hastie et al., 2022), 42% of people with a symptomatic infection reported only partial recovery and 6% reported no recovery when surveyed 6 to 18 months later [16].

What Recovery Actually Looks Like

Long COVID recovery is not a smooth upward line. For most patients it looks more like a staircase with occasional drops: periods of genuine improvement, followed by crashes, followed by plateaus, then more improvement. This pattern is frustrating but it is the norm, not a sign that recovery is failing [1].

Studies tracking Long COVID patients over time show that persistent symptoms are common and that full recovery often takes longer than a year. In the French ComPaRe e-cohort of 968 adults, Tran and colleagues (2022) found that 85% of patients who still had symptoms two months after onset were still reporting symptoms one year later [1]. The UK REACT-2 community survey of more than 500,000 adults found that 37.7% of people who had COVID-19 symptoms still reported at least one symptom at 12 weeks in its main rounds, falling to 21.6% in a later round [2].

Long-term follow-up adds a more hopeful picture. In the Long-COVID in Scotland Study, which followed 33,281 people with confirmed infection for up to 18 months, about half of those with a symptomatic infection reported full recovery, 42% partial recovery and 6% no recovery at their most recent survey [16].

What this tells us is that spontaneous recovery does happen, and at significant rates. It also tells us that a large group does not recover quickly without targeted management, and that waiting passively is not always sufficient. The pacing, rehabilitation and treatment strategies covered in the sections below make a difference to which group you end up in.

How Long Does Long COVID Recovery Take?

Long COVID recovery typically takes 3 to 6 months for mild cases, 12 to 18 months for moderate cases, and 2 years or longer for severe cases that overlap with ME/CFS. These ranges describe what clinicians commonly observe, not a schedule any individual patient will follow. The World Health Organization defines post-COVID-19 condition as symptoms that start within 3 months of infection, last at least 2 months and are not explained by another diagnosis (Soriano et al., 2022) [19].

The UK National Institute for Health and Care Excellence (NICE) uses two time bands: “ongoing symptomatic COVID-19” for symptoms from 4 to 12 weeks, and “post-COVID-19 syndrome” for symptoms beyond 12 weeks [20]. The table below maps those definitions onto a realistic Long COVID recovery timeline.

Recovery Timeline by Severity

Mild Long COVID

Patients with mild Long COVID, meaning one or two symptoms that limit but do not prevent normal activities, often see resolution within 3 to 6 months. Common presentations in this group include persistent fatigue that improves with rest, intermittent brain fog, and mild breathlessness that diminishes over time. For this group, the main risks are ignoring symptoms, pushing too hard too soon, and triggering a more severe course through repeated PEM crashes [3].

Moderate Long COVID

Moderate Long COVID, characterized by multiple symptoms that significantly impair work or daily function, has a more variable timeline. Many patients in this category improve substantially over 12 to 18 months, particularly with appropriate management. Symptoms like POTS, brain fog, and fatigue often respond to targeted treatment over this timeframe. Some patients with moderate severity plateau and require more aggressive intervention to continue improving.

Severe Long COVID

Severe Long COVID, including those who meet full ME/CFS criteria or are largely housebound, has the longest recovery trajectory and the most uncertain prognosis. Some patients in this group have improved significantly over 2 to 3 years with appropriate pacing and treatment. Others remain severely affected for years. Research into biomarkers that predict recovery in this group is ongoing. Early access to specialized care appears to influence outcomes [4].

The Scottish data point to the same risk factors clinicians see in practice. Hastie and colleagues (2022) found that no recovery was associated with having been hospitalized, older age, female sex, deprivation, pre-existing respiratory disease, depression and multiple long-term conditions [16]. Patients whose illness overlaps with chronic fatigue syndrome (ME/CFS) usually need the slowest, most careful approach.

How Does Recovery Differ for People With Long COVID?

Recovery from Long COVID differs from ordinary post-viral recovery in three ways: it takes months instead of weeks, it moves in cycles of improvement and relapse, and exercise can make it worse rather than better. People recovering from an uncomplicated COVID-19 infection can usually return to activity step by step. People with Long COVID, especially those with post-exertional malaise, often need to reduce activity first and rebuild only from a stable baseline.

The difference matters because standard advice can backfire. A graded exercise plan that helps someone deconditioned after a hospital stay can trigger PEM crashes in someone with Long COVID. The table below summarizes how the two recovery paths compare.

For a full list of the symptoms that define the condition, see the Long COVID condition overview.

The Role of Pacing in Recovery

Pacing is the practice of staying within your current energy capacity to avoid triggering post-exertional malaise (PEM). It is not optional for patients with PEM as a feature. Every PEM crash is a setback. Repeated crashes over months can entrench the condition and push back the recovery timeline substantially.

Heart rate-based pacing is the most concrete approach available. Keeping heart rate below the anaerobic threshold, typically around 110 to 120 beats per minute for most adults, during all activities reduces PEM risk significantly. Wrist-worn heart rate monitors and smartwatches provide continuous tracking, and many patients find this objective feedback more useful than trying to gauge exertion subjectively [5].

Cognitive and emotional exertion also trigger PEM, not just physical activity. Stressful conversations, busy environments, screen time, and social events consume energy and count against the daily budget. This often surprises patients who feel fine physically but find their symptoms worsen after a difficult phone call or a trip to a noisy grocery store.

Rebuilding Activity: The Right Way

Pacing is the foundation, but the goal is not permanent inactivity. Once a patient has established a stable baseline of several weeks with no PEM crashes, very gradual activity expansion becomes possible. The approach is sometimes called “staying in the green” or energy envelope management [6].

The process looks like this: identify activities you can do without triggering a crash. Do those consistently for several weeks. If stable, add a small increment of new activity. Wait two weeks before adding more. If a crash occurs, return to the previous level for at least two weeks before trying again. This is slow by conventional standards, but it is how the autonomic and immune systems get a chance to recalibrate.

Aquatic therapy or recumbent exercise (such as recumbent cycling) is often better tolerated than upright exercise for patients with autonomic dysfunction, because it removes the orthostatic challenge. Many Long COVID rehabilitation programs use this as an entry point for reconditioning.

A 90-Day Long COVID Recovery Plan

A 90-day Long COVID recovery plan works best as three 30-day phases: stabilize first, then build routines that support recovery, then expand activity slowly. The plan below draws on the pacing, autonomic rehabilitation and monitoring approaches described elsewhere on this page. It is a structure to discuss with your clinician, not a promise that symptoms will resolve within 90 days.

1. Days 1 to 30, stabilize. Track symptoms, sleep and resting heart rate every day, and find the activity level that does not trigger PEM. Cut activity to that level, use heart rate limits, and ask your clinician about volume loading and compression if you have POTS symptoms.
2. Days 31 to 60, build the foundation. Hold the stable baseline. Work with your clinician on targeted treatment for your dominant symptoms, such as medication for POTS or mast cell symptoms, sleep support, and a review of nutrition and gut health.
3. Days 61 to 90, expand carefully. If you have had several weeks without a crash, add one small increment of activity, ideally recumbent or water-based, and wait two weeks before adding more. Repeat a validated questionnaire such as the Post-COVID Functional Status Scale to see whether function has changed.

Many people will not be recovered at day 90, and that is expected. The aim of the first 90 days is a stable baseline, fewer crashes and a clear picture of which symptoms need specialist care.

How Does Treatment Timing Affect Long COVID Recovery?

Treatment timing affects Long COVID recovery most at two points: during the acute infection, when antiviral treatment and vaccination are linked to a lower risk of developing Long COVID, and in the first months of symptoms, when avoiding repeated PEM crashes protects the recovery trajectory. Once Long COVID is established, the evidence for any single treatment changing the course is weaker.

During the acute infection

In a US Department of Veterans Affairs cohort of 281,793 people with at least one risk factor for severe COVID-19, Xie, Choi and Al-Aly (2023) found that taking nirmatrelvir (Paxlovid) within 5 days of a positive test was associated with a lower risk of post-COVID-19 condition at 180 days [17]. This was an observational study, not a randomized trial. Vaccination was associated with a reduced risk of several persistent symptoms in the Long-COVID in Scotland Study [16].

In the first months of Long COVID

Early pacing, symptom tracking and treatment of dominant symptoms such as POTS give the nervous and immune systems the best conditions to recover. Clinicians who treat Long COVID and ME/CFS consistently report that patients who push through repeated crashes early tend to have a longer course, although this has not been tested in a randomized trial.

When Long COVID is established

Late antiviral treatment has not shown clear benefit. In the STOP-PASC randomized trial at Stanford University, Geng and colleagues (2024) gave a 15-day course of nirmatrelvir-ritonavir to adults who had been ill for an average of 17.5 months and found no significant improvement in core symptoms compared with placebo [18]. Rehabilitation, symptom-targeted medications and, for selected patients, HBOT remain the main options at this stage.

Targeted Medical Interventions

Hyperbaric Oxygen Therapy

Hyperbaric oxygen therapy (HBOT) has one of the few randomized, sham-controlled trials in Long COVID. In that Israeli trial, published in Scientific Reports in 2022, Zilberman-Itskovich and colleagues randomized 73 patients with symptoms lasting at least 3 months to 40 daily sessions of HBOT or a sham treatment, and reported improvements in cognition, energy, sleep and psychiatric symptoms in the HBOT group. The proposed mechanisms, enhanced neuroplasticity, mitochondrial support, reduced neuroinflammation, and improved oxygen delivery, address several drivers of Long COVID simultaneously [7].

For patients who can access and afford it, HBOT is worth discussing early in the moderate-to-severe Long COVID course rather than as a last resort. Earlier intervention, when the nervous system and immune system are still more plastic, may yield better results than late-stage treatment, although that has not been tested directly. The main barriers are cost (typically $10,000 to $25,000 for a full protocol) and the time commitment of 40 or more sessions. HBOT is not FDA cleared for Long COVID, so it is usually cash pay; the hyperbaric oxygen therapy treatment guide explains how protocols, pressures and safety screening work.

If you are comparing providers, the directory of HBOT clinics lists centers by state and city. A hospital-based hyperbaric unit and an independent clinic can differ in pressure, chamber type and medical supervision, so ask each one which Long COVID protocol it uses. The clinical detail behind the trial is covered in our post on HBOT clinical data for Long COVID.

Autonomic Rehabilitation

For patients with dysautonomia and POTS, specific autonomic rehabilitation programs, not general exercise, are appropriate. These programs typically begin with recumbent or water-based exercise that avoids orthostatic stress, then gradually introduce upright postures as tolerance improves. Volume loading, increasing salt and fluid intake to around 3 to 5 grams of sodium and 3 liters of fluid daily, is a foundational intervention that reduces POTS symptoms and supports upright exercise capacity [8].

Compression garments, particularly abdominal binders and compression stockings, help manage blood pooling in the legs and abdomen that drives POTS symptoms. Many patients find these simple interventions meaningfully reduce their daily symptom burden. The POTS treatment guide covers medication and rehabilitation options in more depth.

Medications Supporting Recovery

Several medications are used by Long COVID specialists to address specific mechanisms that impair recovery. Low-dose naltrexone (1.5 to 4.5mg nightly) is used off label to reduce neuroinflammation, and many patients report less fatigue and brain fog, although controlled trial data in Long COVID are still limited. Antihistamines targeting mast cell activation reduce inflammatory signaling in patients with MCAS features. Beta-blockers or ivabradine can control the heart rate dysregulation of POTS, allowing patients to be more functional and exercise within safer parameters [9].

The RECOVER Initiative’s first clinical trial results showed that nirmatrelvir-ritonavir (Paxlovid) extended treatment did not show significant benefit for established Long COVID in most symptom domains, though there was a hint of benefit for specific endpoints. The separate STOP-PASC trial reached a similar conclusion [18]. Research into antivirals for viral persistence continues, with several trials underway.

NAD+ and Mitochondrial Support

Recovery at the cellular level requires rebuilding the energy generation systems that COVID-19 disrupted. NAD+ (nicotinamide adenine dinucleotide) replenishment is one proposed way to support this. IV NAD+ protocols, combined with oral precursors like NR or NMN as maintenance, are intended to support mitochondrial function and the repair pathways that enable tissue recovery [10]. The supporting research is largely laboratory and mechanistic; controlled trials of IV NAD+ in Long COVID are lacking, and the infusions are cash pay.

Coenzyme Q10 (100 to 400mg per day), ribose, and acetyl-L-carnitine support mitochondrial function at the substrate level. Magnesium, in forms with good bioavailability like magnesium glycinate or malate, supports over 300 metabolic reactions including ATP synthesis. These are not magic bullets but they remove nutritional bottlenecks that can slow recovery.

Patients who want to try infusions can read the NAD+ IV therapy guide for typical protocols and side effects, and browse clinics offering NAD+ IV therapy to compare providers.

Gut and Microbiome Recovery

The gut microbiome disruption documented in Long COVID patients can perpetuate immune dysregulation and inflammation long after the virus is cleared. Microbiome recovery supports systemic recovery. This involves removing obstacles to microbiome health, including unnecessary antibiotics, excess alcohol, and highly processed diets, while actively rebuilding beneficial species through fermented foods and targeted probiotics [11].

Specific probiotic strains with evidence in related conditions include Lactobacillus rhamnosus GG, Bifidobacterium longum, and Saccharomyces boulardii. A diverse diet rich in polyphenols and fermentable fiber provides the substrate that beneficial gut bacteria need to thrive. For patients with SIBO symptoms, this sequence matters: treating bacterial overgrowth before attempting to rebuild the microbiome.

Mental Health and Psychological Support

The psychological burden of Long COVID is real and warrants direct address. Having a disabling illness that many people do not understand, that may cost you your job, relationships, and identity, is profoundly stressful. Rates of anxiety and depression in Long COVID cohorts are elevated, and addressing these symptoms is part of recovery, not separate from it [12].

Acceptance and commitment therapy (ACT) has some evidence in chronic illness populations and may be more appropriate than CBT approaches that inadvertently imply symptoms are psychologically generated. Support groups, both in-person and online, provide community and practical information sharing. The Body Politic community and ME/CFS patient networks are particularly active sources of peer support and research updates.

Psychological support should never replace physical treatment or imply that Long COVID is primarily psychological. It is appropriate alongside physical care, as part of a whole-person approach.

Monitoring Your Progress

Tracking symptoms systematically helps both patients and clinicians understand whether interventions are working and when the trajectory has changed. Several validated tools are available. The Post-COVID Functional Status Scale categorizes functional impairment from no limitation to complete inability to perform daily activities. The COMPASS-31 questionnaire screens for autonomic dysfunction severity. The DePaul Symptom Questionnaire is the best-validated tool for PEM assessment [13].

Wearable data, including step counts, resting heart rate trends, and heart rate variability (HRV), can provide objective markers of recovery that correlate with subjective symptom burden. Improving HRV over weeks is generally a positive sign; declining HRV often precedes or accompanies symptom worsening.

Who Treats Long COVID?

Long COVID is treated by a team rather than a single specialist. Primary care physicians usually coordinate care and rule out other diagnoses. Post-COVID clinics, many run by academic medical centers, often bring together physical medicine and rehabilitation (PM&R) physicians, pulmonologists, cardiologists, neurologists, physical and occupational therapists, and mental health clinicians.

Integrative and functional medicine clinics add options such as HBOT, NAD+ infusions, IV therapy and peptide protocols. These services are usually cash pay and mostly off label for Long COVID, so ask any clinic what evidence it relies on, how it screens for PEM and POTS, and how it will measure your progress. The Long COVID treatment guide compares the main options side by side.

When you search the regenerated.com directory, listing order is not paid ranking, Featured slots are labeled and capped, Verified means the clinic completed credential checks rather than paying more, and the directory is free for patients. Inclusion in the directory is not an endorsement; the guide to Featured, Verified and organic listings explains each label.

When to Seek Urgent Help

Most Long COVID symptoms, while disabling, are not immediately dangerous. Some presentations require prompt medical evaluation. Chest pain with exertion, especially new or worsening chest pain, needs cardiac assessment. Significant unintentional weight loss warrants investigation for alternative or additional diagnoses. New neurological deficits, including focal weakness, coordination problems, or speech difficulties, should be evaluated urgently [14].

Severe orthostatic symptoms, including near-fainting or fainting, can be dangerous and should be assessed. Worsening breathlessness at rest, oxygen saturation below 94% on pulse oximetry, or any acute clinical change that feels different from the usual Long COVID pattern is a reason to seek medical attention.

For the ongoing management of established Long COVID, the appropriate setting is a Long COVID specialty clinic where practitioners are familiar with the condition’s complexity. General practitioners, while valuable for many aspects of care, often lack the training to manage the full scope of Long COVID and may inadvertently give advice, like recommending more exercise before PEM is resolved, that delays recovery.

Protecting Your Recovery From Reinfection

Reinfection with SARS-CoV-2 during Long COVID recovery is a recognized cause of relapse and prolonged illness. Cohort studies from the US Department of Veterans Affairs, led by Ziyad Al-Aly, show that each additional infection adds risk of post-acute problems and that breakthrough infections after vaccination can still cause Long COVID [15] [21]. This makes infection prevention an active component of recovery strategy during the period of active illness.

Practical measures include high-quality mask use in high-risk indoor environments, improved ventilation at home and work, and staying up to date with COVID-19 vaccination. This is not paranoia; it is evidence-based risk management for a known trigger of relapse. As recovery stabilizes and the immune system normalizes, these precautions can be gradually relaxed based on individual circumstances.

The Bigger Picture

Long COVID recovery is possible for most patients, though the path is longer and more complex than most people hope when they first develop the condition. Many people improve over 12 to 24 months, while a minority, about 6% of symptomatic people in the Scottish cohort, report no recovery 6 to 18 months on [16]. The research is moving faster than in almost any other area of post-viral illness, and treatment options available today are substantially better than they were two years ago.

Patients who do best tend to be those who understand the condition well enough to avoid the mistakes that prolong it, who work with clinicians who take it seriously, and who combine foundational self-management strategies with targeted biological interventions rather than waiting for a single breakthrough treatment to arrive.

Frequently Asked Questions About Long COVID Recovery

How long does long COVID recovery take?

Long COVID recovery usually takes months. Mild cases often resolve within 3 to 6 months, moderate cases commonly improve over 12 to 18 months, and severe cases that overlap with ME/CFS can take 2 to 3 years or longer. In the Long-COVID in Scotland Study (Hastie et al., 2022), about half of people with a symptomatic infection had fully recovered 6 to 18 months later, 42% had partly recovered and 6% had not recovered.

Does long COVID go away by itself?

Long COVID often improves on its own, but not always, and not quickly. Long-term cohorts show steady recovery over the first one to two years, yet 85% of French ComPaRe patients still symptomatic at two months still had symptoms at one year. Pacing to avoid PEM crashes, treating POTS or sleep problems, and preventing reinfection all improve the odds that spontaneous recovery continues rather than stalls.

How does recovery differ for people with long COVID?

People with Long COVID recover more slowly and less predictably than people who recover from an ordinary COVID-19 infection. Typical recovery takes days to a few weeks and improves steadily with activity. Long COVID recovery takes months, follows a staircase pattern with crashes and relapses, and can worsen with exercise because of post-exertional malaise, so pacing comes before any gradual return to activity.

How does treatment timing affect long COVID recovery?

Treatment timing matters most early. Taking nirmatrelvir within 5 days of a positive test was associated with a lower risk of Long COVID in a large Veterans Affairs cohort (Xie et al., 2023), and early pacing helps prevent repeated crashes. Starting the same antiviral after more than a year of illness showed no significant benefit in the STOP-PASC trial (Geng et al., 2024), so later care focuses on rehabilitation and symptom-targeted treatment.

What should a 90-day long COVID recovery plan include?

A 90-day Long COVID recovery plan should start with 30 days of stabilizing: daily symptom and heart rate tracking, pacing below your PEM threshold, and treatment of POTS if present. The next 30 days hold that baseline while addressing dominant symptoms with a clinician. The final 30 days add small, recumbent increases in activity only after several crash-free weeks, then reassess with a validated scale.

Can long COVID come back after you recover?

Long COVID symptoms can return after a period of improvement. In the Long-COVID in Scotland Study, 11% of participants who answered more than one follow-up survey reported getting worse over time. Common triggers include SARS-CoV-2 reinfection, overexertion that causes post-exertional malaise, other infections and major stress. Keeping a buffer below your energy limit and reducing infection risk lowers the chance of relapse.

Related Reading

• Long COVID Symptoms: The Complete Guide to Post-COVID Syndrome
• Long COVID Treatment: Evidence-Based Options and What Actually Helps
• Post-COVID Fatigue: Why It Happens and How to Recover
• Long COVID Brain Fog Treatment
• Hyperbaric Oxygen Therapy: Benefits, Risks, and What to Expect
• NAD+ IV Therapy: What It Does and Who It Helps

Sources

1. Tran VT, Porcher R, Pane I, Ravaud P. “Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort.” Nat Commun. 2022;13(1):1812. doi:10.1038/s41467-022-29513-z ↩
2. Whitaker M, Elliott J, Chadeau-Hyam M, et al. “Persistent COVID-19 symptoms in a community study of 606,434 people in England.” Nat Commun. 2022;13(1):1957. doi:10.1038/s41467-022-29521-z ↩
3. Sudre CH, Murray B, Varsavsky T, et al. “Attributes and predictors of long COVID.” Nat Med. 2021;27(4):626-631. doi:10.1038/s41591-021-01292-y ↩
4. Komaroff AL, Bateman L. “Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?” Front Med. 2021;7:606824. doi:10.3389/fmed.2020.606824 ↩
5. Davenport TE, Stevens SR, Stevens J, et al. “Chronotropic Intolerance: An Overlooked Determinant of Symptoms and Activity Limitation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?” Front Pediatr. 2019;7:82. doi:10.3389/fped.2019.00082 ↩
6. Jason LA, Brown M, Evans M, et al. “Measuring Substantial Reductions in Functioning in Patients with Chronic Fatigue Syndrome.” Disabil Rehabil. 2011;33(7):589-598. doi:10.3109/09638288.2010.503256 ↩
7. Zilberman-Itskovich S, Catalogna M, Sasson E, et al. “Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial.” Sci Rep. 2022;12(1):11252. doi:10.1038/s41598-022-15565-0 ↩
8. Raj SR, Arnold AC, Barboi A, et al. “Long-COVID postural tachycardia syndrome: an American Autonomic Society statement.” Clin Auton Res. 2021;31(3):365-368. doi:10.1007/s10286-021-00798-2 ↩
9. Johansson M, Ståhlberg M, Widholm M, et al. “Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrome.” JACC Case Rep. 2021;3(4):573-580. doi:10.1016/j.jaccas.2021.01.009 ↩
10. Minhas PS, Liu L, Moon PK, et al. “Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation.” Nat Immunol. 2019;20(1):50-63. doi:10.1038/s41590-018-0255-3 ↩
11. Liu Q, Mak JWY, Su Q, et al. “Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome.” Gut. 2022;71(3):544-552. doi:10.1136/gutjnl-2021-325989 ↩
12. Taquet M, Geddes JR, Husain M, et al. “6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19.” Lancet Psychiatry. 2021;8(5):416-427. doi:10.1016/S2215-0366(21)00084-5 ↩
13. Stevens S, Snell CR, Stevens J, et al. “Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.” Front Pediatr. 2018;6:242. doi:10.3389/fped.2018.00242 ↩
14. Nalbandian A, Sehgal K, Gupta A, et al. “Post-acute COVID-19 syndrome.” Nat Med. 2021;27(4):601-615. doi:10.1038/s41591-021-01283-z ↩
15. Al-Aly Z, Bowe B, Xie Y. “Long COVID after breakthrough SARS-CoV-2 infection.” Nat Med. 2022;28(7):1461-1467. doi:10.1038/s41591-022-01840-0 ↩
16. Hastie CE, Lowe DJ, McAuley A, et al. “Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study.” Nat Commun. 2022;13(1):5663. doi:10.1038/s41467-022-33415-5 ↩
17. Xie Y, Choi T, Al-Aly Z. “Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.” JAMA Intern Med. 2023;183(6):554-564. doi:10.1001/jamainternmed.2023.0743 ↩
18. Geng LN, Bonilla H, Hedlin H, et al. “Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial.” JAMA Intern Med. 2024;184(9):1024-1034. doi:10.1001/jamainternmed.2024.2007 ↩
19. Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. “A clinical case definition of post-COVID-19 condition by a Delphi consensus.” Lancet Infect Dis. 2022;22(4):e102-e107. ↩
20. National Institute for Health and Care Excellence. “COVID-19 rapid guideline: managing the long-term effects of COVID-19.” NICE guideline NG188. 2020. ↩
21. Bowe B, Xie Y, Al-Aly Z. “Acute and postacute sequelae associated with SARS-CoV-2 reinfection.” Nat Med. 2022;28(11):2398-2405. ↩